S&P 500 Financials Sector SEC Filings — February 23, 2026

24-02-2026

Ashford Hospitality Trust Inc filed an 8-K on February 24, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing provides voluntary disclosure of material non-public information with attached exhibits, but specific details, financial metrics, transactions, or events are NOT_DISCLOSED. No quantitative data or directional performance indicators are available from the provided filing information.

24-02-2026

Home Depot, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.

24-02-2026

Clarivate PLC filed an 8-K on February 24, 2026 (AccNo: 0001764046-26-000018, Size: 6 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED in the provided information. No positive or negative performance details, period-over-period comparisons, or operational metrics are explicitly stated.

• ·Filing date: 2026-02-24
• ·Accession Number: 0001764046-26-000018
• ·File size: 6 MB
• ·Sector: NOT_DISCLOSED
• ·Critical missing information: Actual financial results, revenue, EPS, guidance, balance sheet details, period-over-period comparisons, scheduled events, forward-looking statements, and exhibit contents that would enable quantitative analysis

24-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing summary.

24-02-2026

Atomera Inc filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a Material Definitive Agreement, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. This multi-item filing signals a significant contractual event but provides no details on parties, terms, or financial impacts. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

• ·AccNo: 0001683168-26-001269
• ·File size: 727 KB
• ·Sector: NOT_DISCLOSED

24-02-2026

24-02-2026

Armstrong World Industries Inc filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-064950), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

24-02-2026

Aebi Schmidt Holding AG filed an 8-K on 2026-02-24 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, alongside Item 2.02 on results of operations and financial condition, and Item 9.01 on financial statements and exhibits. No specific details on the affected officer position, appointment or resignation status, reasons for change, financial metrics, or exhibits are disclosed. No quantitative data or period-over-period comparisons are provided.

24-02-2026

Tidewater Inc filed a Form 8-K on February 24, 2026 (AccNo: 0001104659-26-018759), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

24-02-2026

Archrock, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.

24-02-2026

Aptose Biosciences Inc. filed a Form 8-K on 2026-02-24 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, or performance comparisons provided. No positive or negative metrics are mentioned, making the disclosure purely informational.

24-02-2026

Protagenic Therapeutics, Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Other events are noted under Item 8.01, with financial statements and exhibits provided under Item 9.01. No quantitative financial metrics, deal values, or specific parties are disclosed.

24-02-2026

ZIFF DAVIS, INC. filed a Form 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided information. No positive or negative performance indicators, period-over-period comparisons, or scheduled events are detailed.

24-02-2026

BANK OF HAWAII CORP filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer involved, position, reason for change, or any quantitative metrics are disclosed.

24-02-2026

News Corp filed an 8-K on February 24, 2026 (AccNo: 0001564708-26-000040, Size: 399 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the 'Other Events' or the nature of any financial statements or exhibits are disclosed in the provided filing summary. This is a multi-item, likely voluntary disclosure with no quantitative metrics or directional implications provided.

24-02-2026

RF Acquisition Corp III filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001581), disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, synergies, regulatory pathway, shareholder impact, or market implications are provided. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

24-02-2026

Tennant Co filed an 8-K on February 24, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This represents a standard financial results announcement with no quantified metrics available for analysis.

24-02-2026

Black Stone Minerals, L.P. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided information. This is an informational filing on financial results with no quantitative metrics available.

24-02-2026

MacroGenics Inc. filed a Form 8-K on February 24, 2026, under Item 8.01 reporting Other Events. No specific details regarding the nature of the events, financial metrics, transaction values, or impacts are disclosed. No positive or negative metrics are mentioned.

24-02-2026

Klotho Neurosciences, Inc. filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details regarding the nature of the agreement, transaction value, financial impacts, or any quantitative metrics are disclosed. No positive or negative performance metrics, comparisons, or scheduled events are mentioned.

24-02-2026

ONE Gas, Inc. filed a Form 8-K on February 24, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, dollar values, or impacts are disclosed.

24-02-2026

HELIX ENERGY SOLUTIONS GROUP INC filed an 8-K on 2026-02-24 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

24-02-2026

Livento Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. Sector is not specified.

• ·AccNo: 0002063628-26-000002
• ·Filing size: 14 KB
• ·Event date: 2026-02-24
• ·Sector: not specified

24-02-2026

Northern Oil & Gas, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03) and Regulation FD disclosure (Item 7.01). No quantitative metrics, deal values, parties involved, synergies, or financial impacts are disclosed in the provided filing information. Item 9.01 references financial statements and exhibits, but specifics are NOT_DISCLOSED.

• ·AccNo: 0001193125-26-064523
• ·Filing Size: 338 KB
• ·Event Type: Merger/Acquisition

24-02-2026

Douglas Dynamics, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified metrics available.

24-02-2026

24-02-2026

Invesco Mortgage Capital Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. Item 9.01 includes financial statements and exhibits. No specific transaction values, terms, parties, financial impacts, or strategic details are disclosed.

24-02-2026

Pelican Acquisition Corp filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001595), disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits related to a merger/acquisition event. No specific details on deal structure, parties, valuation, financial terms, or strategic rationale are explicitly stated in the provided filing summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

24-02-2026

Henry Schein Inc filed an 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics were disclosed in the provided filing summary. This is a standard voluntary earnings disclosure with attached exhibits.

• ·AccNo: 0001000228-26-000010
• ·File size: 533 KB
• ·Sector: NOT_DISCLOSED

24-02-2026

Elanco Animal Health Inc filed an 8-K on February 24, 2026 (AccNo: 0001739104-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings announcements, but no specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed. Filing size is 537 KB, indicating potential exhibits with further information.

24-02-2026

Interface Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0000715787-26-000002, Size: 4 MB), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing appears to report financial results on a voluntary basis ahead of periodic reports. No specific revenue, earnings, guidance, or other quantitative metrics were explicitly stated in the provided filing description.

24-02-2026

CECO Environmental Corp filed a Form 8-K on 2026-02-24 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are provided in the filing details. No positive or negative metrics, guidance, or impacts are detailed.

24-02-2026

Xenia Hotels & Resorts, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001628280-26-010860), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results but provides no specific revenue, earnings, balance sheet, or guidance details. No positive or negative metrics, period-over-period changes, or other quantitative data are mentioned.

24-02-2026

Planet Fitness, Inc. filed an 8-K on 2026-02-24 under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

24-02-2026

Palvella Therapeutics, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or performance comparisons are mentioned.

24-02-2026

InfuSystem Holdings, Inc filed an 8-K on 2026-02-24 under Item 2.02 reporting results of operations and financial condition. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data were disclosed in the provided filing information. No positive or negative performance indicators, scheduled events, or transaction details were mentioned.

24-02-2026

Atlantic Union Bankshares Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for changes, timing details, or quantitative data are provided.

24-02-2026

Constellation Energy Corp filed an 8-K on February 24, 2026 (AccNo: 0001868275-26-000029), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or period-over-period comparisons in the available metadata. No positive, negative, or flat metrics are detailed.

24-02-2026

Option Care Health, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, or other quantitative metrics are disclosed in the provided information. No period-over-period comparisons, guidance, or other financial details are available.

24-02-2026

Ferguson Enterprises Inc. /DE/ filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure in the US equity markets. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details.

• ·Sector: not specified
• ·Filing size: 483 KB
• ·AccNo: 0002011641-26-000002

24-02-2026

Life Time Group Holdings, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001869198-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

24-02-2026

Beam Therapeutics Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-065191), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, financial metrics, dollar values, or performance comparisons disclosed. No positive or negative metrics are provided, resulting in purely informational disclosure.

24-02-2026

AMERICAN TOWER CORP /MA/ filed a Form 8-K on February 24, 2026 (AccNo: 0001053507-26-000032), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard mandatory earnings-related disclosure without detailed performance data.

24-02-2026

Fulcrum Therapeutics, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing description. This appears to be a standard voluntary disclosure of financial results with attached exhibits.

24-02-2026

Bowhead Specialty Holdings Inc. filed an 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned.

24-02-2026

Larimar Therapeutics, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-065186, Size: 25 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information.

24-02-2026

Arvinas, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010865), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure typical for earnings releases.

24-02-2026

Axogen, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the available information. No positive or negative performance indicators, period-over-period changes, or strategic details are explicitly stated.

24-02-2026

AVANOS MEDICAL, INC. filed a Form 8-K on February 24, 2026 (AccNo: 0001606498-26-000002), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

24-02-2026

DigitalOcean Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

24-02-2026

Orthofix Medical Inc. filed an 8-K on February 24, 2026, under Item 2.02 for results of operations and financial condition, Item 7.01 for Regulation FD disclosure, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.

24-02-2026

Keurig Dr Pepper Inc. filed an 8-K on 2026-02-24 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, guidance, or strategic details are mentioned.

24-02-2026

Advanced Micro Devices Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction sizes, financial impacts, or other metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative or qualitative context for assessment.

24-02-2026

Shoals Technologies Group, Inc. filed an 8-K on February 24, 2026, solely under Item 9.01: Financial Statements and Exhibits. No specific financial statements, exhibits, transactions, metrics, or events are detailed in the provided filing information. This appears to be an informational filing with no disclosed positive or negative developments.

24-02-2026

Ryman Hospitality Properties, Inc. filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are mentioned. This is a multi-item mandatory earnings-related disclosure.

• ·AccNo: 0001104659-26-018817
• ·Filing size: 3 MB

24-02-2026

Sotera Health Co filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. Key details on the affected position, appointment/resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other specifics are provided.

24-02-2026

AdaptHealth Corp. filed an 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing description. This is a standard post-earnings disclosure without detailed performance data.

24-02-2026

Xometry, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, nature of the change, reasons, timing, or compensation terms are disclosed.

24-02-2026

ALBANY INTERNATIONAL CORP /DE/ filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010871), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on earnings-related disclosures.

24-02-2026

First Watch Restaurant Group, Inc. filed an 8-K on 2026-02-24 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). The filing pertains to an officer change event, but specific details including the affected position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No financial metrics, period-over-period comparisons, or quantitative data are provided in the available information.

24-02-2026

Leonardo DRS, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001833756-26-000009), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or quantitative metrics are explicitly stated in the provided filing details. Sector is not specified.

24-02-2026

Westlake Corp filed an 8-K on February 24, 2026 (AccNo: 0001262823-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or quantitative metrics are provided in the excerpt. All financial impacts, period-over-period changes, and other numerical data are NOT_DISCLOSED.

24-02-2026

Westlake Chemical Partners LP filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. No period-over-period comparisons, guidance, or transaction details are provided in the available information.

24-02-2026

Haverty Furniture Companies Inc filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-010875), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.

24-02-2026

Fidelity National Information Services, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

24-02-2026

NRG Energy, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 9.01 providing Financial Statements and Exhibits. This is a multi-item filing standard for financial results announcements. No quantitative financial metrics, period-over-period changes, guidance, or other specific data points are disclosed in the provided filing information.

24-02-2026

Kiniksa Pharmaceuticals International, plc filed an 8-K on February 24, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

24-02-2026

Thermon Group Holdings, Inc. filed a Form 8-K on 2026-02-24 under Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing representing a material event, but specific details of the agreement, transaction terms, financial impacts, or any metrics are NOT_DISCLOSED.

24-02-2026

Cipher Mining Inc. filed a multi-item Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This filing discloses financial results alongside governance changes, but specific details on operations, amendments, financial metrics, or performance are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional impacts are provided in the available information.

24-02-2026

Repligen Corp filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-065246), reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. This represents a standard voluntary earnings disclosure with attached materials.

24-02-2026

Digi Power X Inc. filed a Form 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure likely including material non-public information and attached exhibits such as a press release. No specific financial metrics, transactions, events, positive or negative changes, or quantitative data are disclosed in the provided filing summary.

24-02-2026

Xilio Therapeutics, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-065234), reporting under Item 5.07 the submission of matters to a vote of security holders. No specific details on the shareholder meeting, proposals voted on, vote outcomes, or any numerical results are disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure with no financial metrics, transaction values, or impacts mentioned.

24-02-2026

Willis Lease Finance Corp filed an 8-K on 2026-02-24 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). No specific details on the agreement, financial terms, parties, or impacts are provided in the filing summary. No quantitative metrics, positive or negative changes, or comparisons are mentioned.

24-02-2026

Twin Vee PowerCats, Co. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)
• ·Accession Number: 0001731122-26-000289
• ·File size: 669 KB

24-02-2026

ENVIRI Corp filed a Form 8-K on February 24, 2026 (AccNo: 0000045876-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard voluntary earnings release filing.

24-02-2026

Portillo's Inc. filed an 8-K on February 24, 2026 (AccNo: 0001871509-26-000011, Size: 4 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed results available.

24-02-2026

Diversified Healthcare Trust filed an 8-K on February 24, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with the filing size of 10 MB. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary. This appears to be a voluntary disclosure to ensure fair dissemination of material information, accompanied by exhibits.

24-02-2026

Atlanta Braves Holdings, Inc. filed a Form 8-K on February 24, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, quantitative data, or events are detailed in the filing summary provided. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance with attached exhibits.

24-02-2026

UFP Industries Inc filed a Form 8-K on 2026-02-24 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), marking a multi-item voluntary disclosure likely including attached exhibits such as a press release or presentation (file size 4 MB). No financial metrics, transactions, or specific events are detailed in the filing metadata. Critical content from exhibits is missing, limiting assessment of impacts.

• ·Accession Number: 0000912767-26-000010

24-02-2026

ESTABLISHMENT LABS HOLDINGS INC. filed an 8-K on February 24, 2026 (AccNo: 0001688757-26-000014), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period changes, or other quantitative details are disclosed in the provided filing information. This is a multi-item informational filing with no directional data available.

24-02-2026

Clene Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified impacts or directional biases evident.

24-02-2026

Iovance Biotherapeutics, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. All detailed revenue, earnings, guidance, or balance sheet impacts are NOT_DISCLOSED.

24-02-2026

FIRST HAWAIIAN, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative impacts are disclosed.

24-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-24 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, in the context of a merger/acquisition event. No quantitative data, deal terms, financial metrics, parties involved, or other specific details are disclosed. Sector is not specified.

24-02-2026

Inhibitor Therapeutics, Inc. filed a Form 8-K on 2026-02-24 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, dollar values, parties involved, or impacts are provided in the filing summary.

24-02-2026

Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-24 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, performance comparisons, or scheduled events are mentioned.

24-02-2026

SCI Engineered Materials, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 reports financial statements and exhibits. No specific details, names, dates, financial impacts, or directional implications (positive or negative) are provided.

24-02-2026

NexPoint Residential Trust, Inc. filed an 8-K on February 24, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, period-over-period comparisons, or performance details such as revenue, earnings, margins, or changes are mentioned. This is a standard voluntary filing for financial results with no quantified positive or negative impacts disclosed.

24-02-2026

Advantage Solutions Inc. filed a Form 8-K on 2026-02-24 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing, but specific details of the agreement, transaction value, financial impacts, or any positive/negative metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional indicators are provided.

24-02-2026

Harmony Biosciences Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings releases, but specific financial metrics including revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are detailed.

24-02-2026

Cadrenal Therapeutics, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001213900-26-019606, size: 224 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the financial statements and exhibits are disclosed. This appears to be a multi-item informational filing with no quantified metrics or directional performance indicators provided.

24-02-2026

Playboy, Inc. filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are mentioned. This is a standard voluntary earnings-related disclosure without detailed performance data.

24-02-2026

Modular Medical, Inc. filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

24-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition, along with unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, deal size, valuation, or financial metrics are disclosed in the provided filing summary. This appears to be a standard SPAC business combination announcement without detailed terms.

24-02-2026

Golden Matrix Group, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative metrics are mentioned.

24-02-2026

NightFood Holdings, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001493152-26-007828, Size: 246 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing with no specific financial metrics, transactions, or events detailed in the provided information. Sector is not specified.

24-02-2026

Microbot Medical Inc. filed an 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing summary. This appears to be a voluntary informational filing with attached exhibits.

24-02-2026

HeartCore Enterprises, Inc. filed a Form 8-K on February 24, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the nature of the disclosures, events, financial statements, or exhibits are provided in the filing summary. This is a multi-item informational filing with no quantified metrics or directional impacts disclosed.

24-02-2026

Protara Therapeutics, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001213900-26-019617, Size: 29 MB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely containing material non-public information disclosures and attached exhibits, but specific details of the events, transactions, or financial data are NOT_DISCLOSED in the provided information. No quantitative metrics, period-over-period comparisons, or directional impacts are mentioned.

24-02-2026

Adial Pharmaceuticals, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements/exhibits are disclosed in the filing summary provided. This is a multi-item, likely voluntary disclosure without quantified financial metrics or directional impacts.

24-02-2026

MAIA Biotechnology, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of a material event with attached exhibits.

24-02-2026

SharonAI Holdings, Inc. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details, numerical values, named parties, financial impacts, or other metrics are provided.

24-02-2026

INVO Fertility, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing signals a completed merger/acquisition transaction, but no specific parties, terms, values, or impacts are disclosed. No quantitative metrics, positive or negative changes, or performance variations are provided.

24-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, with financial statements and exhibits under Item 9.01. No specific deal terms, financial metrics, parties involved, or performance comparisons are disclosed.

• ·AccNo: 0001929980-26-000053
• ·Filing size: 240 KB

24-02-2026

Microvision, Inc. filed a multi-item Form 8-K on February 24, 2026 (AccNo: 0001493152-26-007835), reporting Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, percentages, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics, guidance changes, or scheduled events are mentioned.

24-02-2026

Oncolytics Biotech Inc. filed a Form 8-K on February 24, 2026, disclosing an event under Item 8.01 Other Events. No specific details, financial metrics, transaction values, or quantitative data are provided in the filing summary. This is a single-item filing with no mentioned positive or negative impacts.

24-02-2026

Pioneer Power Solutions, Inc. filed a Form 8-K on 2026-02-24 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information to ensure broad public access and attaches relevant exhibits. No specific transaction details, financial metrics, guidance, or quantitative data are disclosed in the provided filing information.

24-02-2026

Chewy, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, names, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, or performance comparisons are provided.

24-02-2026

Edesa Biotech, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, quantitative metrics, or strategic implications are disclosed in the filing metadata. The filing size is 204 KB with Accession Number 0001171843-26-001046.

24-02-2026

24-02-2026

Main Street Capital CORP filed an 8-K on February 24, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or directional impacts are mentioned.

24-02-2026

Expeditors International of Washington Inc filed an 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing information. This appears to be a standard voluntary earnings release without detailed performance data available.

24-02-2026

SENTIENT BRANDS HOLDINGS INC. filed a Form 8-K on 2026-02-24 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, personnel changes, events, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

24-02-2026

AB International Group Corp. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed. This is a multi-item mandatory filing with no specified positive or negative metrics.

• ·Accession Number: 0001663577-26-000043
• ·Filing size: 492 KB
• ·Sector: NOT_DISCLOSED

24-02-2026

SunCoke Energy, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or further governance implications provided.

24-02-2026

NEW PEOPLES BANKSHARES INC filed a Form 8-K on February 24, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other event, transaction, financial impacts, or contents of the exhibits are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or strategic implications are provided.

24-02-2026

Bravo Multinational Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative performance metrics are mentioned.

24-02-2026

BIO-PATH HOLDINGS, INC. filed a Form 8-K on February 24, 2026, disclosing events under Item 5.01 (Changes in Control of Registrant), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 8.01 (Other Events). This is a multi-item filing covering significant governance changes and voluntary disclosures, with no financial metrics, transaction values, or quantitative data provided in the filing summary. No positive or negative performance indicators are mentioned.

24-02-2026

Summit Networks Inc. filed a Form 8-K on 2026-02-24 (AccNo: 0001091818-26-000022) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details such as the key position affected, names of individuals, reasons for the change, timing, internal/external status, or board composition impacts are provided. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

eXp World Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or performance details are disclosed.

24-02-2026

Gladstone Land Corp filed an 8-K on February 24, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were provided in the filing description. This is a standard voluntary earnings-related disclosure with no detailed financial impacts or strategic updates mentioned.

24-02-2026

Marqeta, Inc. filed an 8-K on February 24, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

24-02-2026

SPX Technologies, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results with attached statements or exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details.

24-02-2026

Grindr Inc. filed an 8-K on February 24, 2026, reporting Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing focused on governance disclosure related to proxy access rules. No financial metrics, quantitative data, or performance indicators (positive, negative, or flat) were disclosed.

24-02-2026

Realty Income Corp filed a Form 8-K on February 24, 2026 (AccNo: 0000726728-26-000009), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item voluntary disclosure typical for quarterly financial results announcements. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing details.

24-02-2026

Jazz Pharmaceuticals plc filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing summary. Sector information is not specified.

24-02-2026

Yext, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

24-02-2026

374Water Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

24-02-2026

BCB Bancorp Inc filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. Filing accession number 0001193125-26-066971, size 136 KB.

24-02-2026

Inogen Inc filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other metrics are provided in the available information. No period-over-period comparisons, guidance, or balance sheet details are mentioned.

24-02-2026

RCM Technologies, Inc. filed an 8-K on February 24, 2026 (AccNo: 0000929638-26-000744), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, terms, or financial metrics are provided in the filing summary.

24-02-2026

Tanger Inc. filed an 8-K on 2026-02-24 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, guidance, comparisons, or other quantitative financial metrics are disclosed.

• ·AccNo: 0001628280-26-011057
• ·File Size: 27 MB
• ·Event Type: Financial Results

24-02-2026

Climb Global Solutions, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001437749-26-005335), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

24-02-2026

Tectonic Therapeutic, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details such as the key position affected, individual name, appointment or resignation status, reason, or timing are NOT_DISCLOSED.

24-02-2026

Mobile Infrastructure Corp filed an 8-K on February 24, 2026, under Item 8.01 Other Events. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing information. This is a single-item filing with no mentioned positive or negative impacts.

24-02-2026

Zeta Global Holdings Corp. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-066951), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard voluntary earnings release filing with no quantitative data available.

24-02-2026

CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-066949), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

24-02-2026

TransMedics Group, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-066953, Size: 498 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no directional performance indicators available.

24-02-2026

Finward Bancorp filed an 8-K on 2026-02-24 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, but no specific details on individuals, reasons, timing, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

24-02-2026

CoStar Group, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, but lacks quantitative data for impact assessment.

24-02-2026

BridgeBio Pharma, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.

24-02-2026

Vestis Corp filed an 8-K on February 24, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, share counts, or results are provided in the filing summary. No financial metrics, changes, or other quantitative data mentioned.

24-02-2026

CareDx, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, margins, or other metrics are NOT_DISCLOSED in the provided filing information. No positive, negative, or flat performance indicators are available.

24-02-2026

ServisFirst Bancshares, Inc. filed a Form 8-K on February 24, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing provides voluntary public disclosure of material information to comply with Regulation FD, with exhibits attached for support. No specific financial metrics, transactions, positive or negative changes, or quantitative data are disclosed in the filing metadata.

24-02-2026

Workday, Inc. filed an 8-K on 2026-02-24 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the provided filing details. No positive, negative, or flat performance metrics available for analysis.

24-02-2026

Entrepreneur Universe Bright Group filed Form 8-K on February 24, 2026, reporting Item 3.03 (Material Modifications to Rights of Security Holders) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), with Item 9.01 listing Financial Statements and Exhibits. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the modifications/amendments are disclosed. This is a multi-item mandatory filing focused on governance changes.

24-02-2026

Tempus AI, Inc. filed an 8-K on 2026-02-24 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary earnings-related filing with no specific revenue, earnings, or other financial metrics detailed in the provided information. No period-over-period comparisons, guidance, or quantitative impacts are disclosed.

24-02-2026

XCel Brands, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, parties, or impacts are provided in the filing summary.

24-02-2026

Carlyle Secured Lending, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001544206-26-000012, Size: 6 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed.

24-02-2026

MercadoLibre Inc filed a Form 8-K on February 24, 2026 (AccNo: 0001099590-26-000003, Size: 5 MB), under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This multi-item filing announces financial results but provides no specific metrics on revenue, earnings, guidance, or other quantitative data. No positive, negative, or flat performance indicators are detailed.

24-02-2026

Cohen Circle Acquisition Corp. II filed an 8-K on February 24, 2026 (AccNo: 0001213900-26-019871, Size: 288 KB), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, terms, financial metrics, synergies, regulatory pathway, or shareholder impacts were explicitly stated. Sector not specified, and no quantitative data, comparisons, or scheduled events provided.

24-02-2026

BTC Development Corp. filed a Form 8-K on February 24, 2026 (AccNo: 0001213900-26-019870, Size: 265 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided.

24-02-2026

Day One Biopharmaceuticals, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-066926), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or quantitative data are disclosed in the provided filing details. This is a multi-item filing focused on financial results disclosure.

• ·Filing size: 29 MB
• ·Sector: NOT_DISCLOSED

24-02-2026

First Solar, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001274494-26-000020), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are disclosed in the provided information. No positive or negative performance indicators, guidance revisions, or balance sheet details are mentioned.

24-02-2026

CVR Energy Inc filed a Form 8-K on February 24, 2026 (AccNo: 0001376139-26-000016, Size: 5 MB), disclosing information under Item 7.01 Regulation FD Disclosure and attaching financial statements and exhibits under Item 9.01. No specific details on the content of the disclosure, exhibits, financial metrics, transactions, or events are provided in the filing summary.

24-02-2026

MGE Energy Inc filed a Form 8-K on February 24, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

24-02-2026

HP Inc filed an 8-K on February 24, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance details.

24-02-2026

Astronics Corp filed a Form 8-K on February 24, 2026 (AccNo: 0000008063-26-000018, Size: 739 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item, mandatory disclosure for financial results with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics disclosed in the provided information. No positive or negative financial changes are available for analysis.

24-02-2026

EOG Resources Inc filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other metrics. No positive or negative performance indicators, guidance, or comparisons are detailed.

24-02-2026

LTC Properties Inc filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019132), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed. Sector is not specified.

24-02-2026

Axon Enterprise, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011106), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This represents a standard voluntary disclosure of financial results.

24-02-2026

MOSAIC CO filed an 8-K on February 24, 2026 (AccNo: 0001285785-26-000013), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational disclosure typical for earnings releases.

24-02-2026

Tandy Leather Factory Inc filed an 8-K on February 24, 2026 (AccNo: 0001140361-26-006558), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are explicitly stated in the provided filing information. This appears to be a standard voluntary earnings disclosure with attached exhibits containing undisclosed details.

• ·Sector: not specified
• ·Filing size: 416 KB

24-02-2026

Starfighters Space, Inc. filed a Form 8-K on February 24, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. Item 9.01 reports financial statements and exhibits, likely including the amended documents. No specific details on the nature or impact of the changes, transaction values, financial metrics, or strategic implications are provided.

24-02-2026

Resideo Technologies, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001740332-26-000003, Size: 729 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results but no specific revenue, earnings, margins, or period-over-period comparisons are explicitly stated in the provided filing information. No positive or negative metrics, guidance, or balance sheet effects are detailed.

24-02-2026

ONITY GROUP INC. filed an 8-K on February 24, 2026 (AccNo: 0001493152-26-007881) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, timing details, numerical values, or other quantitative data are disclosed in the provided filing information.

24-02-2026

Adtalem Global Education Inc. filed an 8-K on 2026-02-24 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), with file size 18 MB. No specific events, transactions, financial metrics, positive or negative changes, or other details are disclosed in the provided filing summary.

24-02-2026

Standard BioTools Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067026), furnishing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits) related to financial results. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

24-02-2026

TREX CO INC filed an 8-K on 2026-02-24 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 8.01 covers other events, and Item 9.01 lists financial statements and exhibits. No specific details on affected positions, names, reasons for change, or financial metrics are disclosed.

24-02-2026

Revolve Group, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other financial metrics, comparisons, positives, negatives, or flat performances were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data.

24-02-2026

Western Digital Corp filed an 8-K on February 24, 2026, reporting amendments to Articles of Incorporation or Bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, numerical metrics, positive or negative changes, or transaction values are disclosed in the provided filing summary.

24-02-2026

Clean Energy Fuels Corp. filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019128), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data.

24-02-2026

AbCellera Biologics Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a multi-item filing typical for quarterly financial results announcements, with no quantitative data available for analysis.

24-02-2026

Flywire Corp filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067020, Size: 13 MB), disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases with attached exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

24-02-2026

Verra Mobility Corp filed an 8-K on February 24, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases.

24-02-2026

Merit Medical Systems Inc filed an 8-K on February 24, 2026 (AccNo: 0000856982-26-000007, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing information. No positive or negative performance indicators are available.

24-02-2026

Vaxcyte, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02 and including financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were disclosed in the provided filing information. No positive or negative financial metrics were mentioned.

24-02-2026

Supernus Pharmaceuticals, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001356576-26-000004), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are mentioned in the filing. Sector information is not specified.

24-02-2026

Cytokinetics Inc filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were provided in the filing details. This represents a standard mandatory disclosure for financial results without quantified directional impacts.

24-02-2026

Valley National Bancorp filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transactions, or directional performance indicators mentioned.

24-02-2026

Leggett & Platt Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or financial impacts were provided.

24-02-2026

Rocky Brands, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001437749-26-005341), disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. Sector details are not specified.

24-02-2026

Huron Consulting Group Inc. filed a Form 8-K on 2026-02-24 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

24-02-2026

Evolent Health, Inc. filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a standard earnings-related 8-K with no quantified financial impacts or directional signals provided.

24-02-2026

CAVA GROUP, INC. filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.

24-02-2026

ExlService Holdings, Inc. filed a Form 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative details available.

24-02-2026

Tigo Energy, Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the filing details. This is an informational earnings-related disclosure without detailed performance data.

24-02-2026

FrontView REIT, Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were detailed in the provided filing information. This is a multi-item filing focused on financial results announcement.

24-02-2026

Solid Power, Inc. filed an 8-K on February 24, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the filing description. This represents a standard earnings-related disclosure without quantified financial impacts.

24-02-2026

Camping World Holdings, Inc. filed a Form 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with no quantified metrics provided.

24-02-2026

GoDaddy Inc. filed an 8-K on February 24, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified impacts.

24-02-2026

Universal Insurance Holdings, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. No positive or negative metrics are available for balanced assessment.

24-02-2026

Veradigm Inc. filed a Form 8-K on February 24, 2026, under Item 8.01 Other Events. No specific details regarding the event, transactions, financial metrics, or impacts are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

24-02-2026

Matson, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001104659-26-019116), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results with exhibits attached.

24-02-2026

Navitas Semiconductor Corp filed an 8-K on 2026-02-24 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

24-02-2026

Gulfport Energy Corp filed an 8-K on February 24, 2026 (AccNo: 0001213900-26-019884, Size: 718 KB), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing is typical for quarterly or annual financial results announcements. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

24-02-2026

Corcept Therapeutics Inc filed a Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, or other quantitative metrics are mentioned in the provided filing details. All financial impacts, guidance, and performance comparisons are NOT_DISCLOSED.

24-02-2026

Light & Wonder, Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.

24-02-2026

SUN Communities Inc filed an 8-K on February 24, 2026 (AccNo: 0000912593-26-000073), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure with attached exhibits.

24-02-2026

New Mountain Finance Corp filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

24-02-2026

BlueLinx Holdings Inc. filed an 8-K on February 24, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are explicitly stated in the provided filing details. This is an informational earnings-related disclosure with no directional financial data available.

24-02-2026

First Western Financial Inc filed an 8-K on February 24, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, or performance details are disclosed in the provided filing information. This appears to be a voluntary disclosure with attached exhibits, but content details are NOT_DISCLOSED.

24-02-2026

Dillard's, Inc. filed an 8-K on February 24, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed performance data.

24-02-2026

BOSTON BEER CO INC filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067142), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed directional data.

24-02-2026

Globus Medical Inc filed an 8-K on 2026-02-24 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No quantitative financial metrics, revenue, earnings, guidance, or period-over-period comparisons are explicitly stated in the provided filing details. This is a standard earnings-related disclosure with no directional performance indicators available.

24-02-2026

Ceribell, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067136), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings announcements.

24-02-2026

Amplitude, Inc. filed an 8-K on 2026-02-24 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

24-02-2026

Lucid Group, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, Item 2.05 for Costs Associated with Exit or Disposal Activities, Item 8.01 for Other Events, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing covers financial results alongside costs from exit or disposal activities, which may indicate restructuring efforts. No specific financial metrics, dollar amounts, or performance details are disclosed in the provided filing summary.

24-02-2026

MetLife Inc filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067070), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any financial/quantitative impacts are disclosed. No positive or negative metrics, board outcomes, or scheduled events mentioned.

24-02-2026

Slide Insurance Holdings, Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067069, Size: 688 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no directional performance data available.

24-02-2026

MIDDLESEX WATER CO filed Form 8-K on 2026-02-24 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific terms, transaction details, financial metrics, or impacts are disclosed.

24-02-2026

Alphatec Holdings, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with attached exhibits.

24-02-2026

Boyd Gaming Corp filed an 8-K on February 24, 2026 (AccNo: 0001193125-26-067254), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any impacts are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

Benchmark Electronics Inc filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.

24-02-2026

Unisys Corp filed a Form 8-K on February 24, 2026, under Item 2.02 disclosing results of operations and financial condition, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This multi-item filing represents a standard voluntary earnings-related disclosure with no detailed performance data available.

24-02-2026

DENTSPLY SIRONA Inc. filed an 8-K on 2026-02-24 disclosing changes related to departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. Specific details on affected positions, individuals, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

24-02-2026

Luxfer Holdings PLC filed a Form 8-K on February 24, 2026 (AccNo: 0001096056-26-000014, size: 3 MB), reporting solely under Item 9.01 Financial Statements and Exhibits. No specific financial statements, transactions, metrics, events, or other details are explicitly stated in the filing description. This is an informational attachment filing with no disclosed directional impacts.

24-02-2026

PGIM Private Credit Fund filed an 8-K on February 24, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details on events, transactions, financial metrics, or numerical data are disclosed in the filing information provided. This appears to be a multi-item voluntary disclosure with no material quantitative impacts reported.

24-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on 2026-02-24 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were mentioned in the filing summary. All quantitative financial metrics are NOT_DISCLOSED.

24-02-2026

Energy Services of America CORP filed an 8-K on February 24, 2026, under Item 8.01 for Other Events and Item 9.01 for Financial Statements and Exhibits. No specific details on the nature of the other event, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with attached exhibits, but content of the event and exhibits is not specified.

24-02-2026

Archer Aviation Inc. filed a Form 8-K on February 24, 2026 (AccNo: 0001824502-26-000008, Size: 181 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative details are provided in the filing summary. This is a voluntary, single-item disclosure with no specified core event or implications.

24-02-2026

Aptiv PLC filed a Form 8-K on February 24, 2026, specifically under Item 8.01 Other Events. No details on the nature of the event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.

24-02-2026

Shake Shack Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a matter related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics, scheduled events, or financial impacts are mentioned.

24-02-2026

SILGAN HOLDINGS INC filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011139), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of any exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantified financial or operational metrics provided.

24-02-2026

Walt Disney Co filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.

24-02-2026

Sila Realty Trust, Inc. filed an 8-K on February 24, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is a standard voluntary disclosure for financial results without quantified metrics.

24-02-2026

Unitil Corp filed an 8-K on 2026-02-24 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, value, strategic importance, financial impacts, or any quantitative metrics are provided. This is a multi-item mandatory filing with no directional financial data disclosed.

24-02-2026

ADT Inc. filed an 8-K on February 24, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or other details are disclosed in the filing summary provided.

24-02-2026

Everus Construction Group, Inc. filed a Form 8-K on February 24, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but no specific revenue, earnings, or other quantitative metrics are provided in the filing details. No positive or negative performance indicators, guidance, or scheduled events were mentioned.

24-02-2026

Matador Resources Co filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011137), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for financial results announcements, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators are available.

24-02-2026

Sono Group N.V. filed a Form 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits provided under Item 9.01. No specific transaction details, financial terms, dollar values, share counts, or impacts are disclosed in the provided information. This is a multi-item filing representing mandatory disclosures of potentially strategic and dilutive events.

24-02-2026

Republic Bancorp Inc /KY/ filed an 8-K on February 24, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This is a voluntary disclosure with no quantitative data or directional impacts mentioned.

24-02-2026

Once Upon a Farm, PBC filed a Form 8-K on February 24, 2026 (AccNo: 0001193125-26-067197), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for the change, or governance impacts are provided. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

Compass Diversified Holdings filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. No positive or negative quantitative metrics are mentioned.

24-02-2026

American Integrity Insurance Group, Inc. filed a Form 8-K on 2026-02-24 reporting financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are disclosed in the provided information. No positive or negative performance details, guidance, or balance sheet impacts are mentioned.

24-02-2026

Business First Bancshares, Inc. filed an 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons provided.

24-02-2026

CONSUMER PORTFOLIO SERVICES, INC. filed an 8-K on February 24, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed in the provided filing information. Sector is not specified.

24-02-2026

Ocean Power Technologies, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. All quantitative metrics, transaction details, and strategic implications are NOT_DISCLOSED.

24-02-2026

24-02-2026

SLR Investment Corp. filed an 8-K on February 24, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing summary. All quantitative financial metrics and impacts are NOT_DISCLOSED.

24-02-2026

GLOBAL INDUSTRIAL Co filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011155, Size: 430 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results and related exhibits, but no specific revenue, earnings, guidance, or performance metrics are mentioned. No positive or negative financial changes are detailed.

24-02-2026

UFP Technologies Inc filed an 8-K on February 24, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the nature, terms, parties, or financial impact of the agreement are provided. Filing size is 169 KB with AccNo 0001628280-26-011154.

24-02-2026

Apple Inc. filed an 8-K on February 24, 2026, reporting Item 5.07 on the submission of matters to a vote of security holders, which typically discloses results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 covers financial statements and exhibits, but no specific details, outcomes, or metrics are provided. No financial impacts, vote results, or other quantitative data are disclosed.

24-02-2026

HANMI FINANCIAL CORP filed an 8-K on 2026-02-24 disclosing under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or performance comparisons are mentioned in the filing summary. The file size is 10 MB, indicating potential attachments such as presentations or statements.

• ·AccNo: 0001171843-26-001062

24-02-2026

Bark, Inc. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011180), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed. Sector is not specified.

24-02-2026

W. P. Carey Inc. filed a Form 8-K on 2026-02-24 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons mentioned.

24-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-24 (AccNo: 0001213900-26-019945, Size: 334 KB) disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders in connection with a Merger/Acquisition event. No specific details on vote results, parties involved, deal structure, financial terms, or metrics are provided. Sector is not specified.

24-02-2026

24-02-2026

Cardiff Oncology, Inc. filed an 8-K on 2026-02-24 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No quantitative metrics, deal details, or performance comparisons are disclosed.

24-02-2026

24-02-2026

Concentrix Corp filed an 8-K on 2026-02-24 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 providing Financial Statements and Exhibits. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

24-02-2026

PALOMA ACQUISITION CORP I filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties, structure, valuation, terms, or metrics are disclosed.

24-02-2026

Ameris Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000351569-26-000026, Size: 142 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Specific details including key positions affected, individuals involved, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or governance implications are mentioned.

• ·Filing size: 142 KB

24-02-2026

CION Investment Corp filed an 8-K on February 24, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or scheduled events are mentioned.

24-02-2026

Fifth Third Bancorp filed an 8-K on February 24, 2026 (AccNo: 0000035527-26-000126), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance metrics, or scheduled events are mentioned.

24-02-2026

Art Technology Acquisition Corp. filed an 8-K on 2026-02-24 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, financial details, transaction information, or quantitative metrics are mentioned in the filing summary. No positive or negative performance indicators, scheduled events, or M&A details are provided.

24-02-2026

Contango ORE, Inc. filed an 8-K on 2026-02-24 (AccNo: 0001193125-26-067410, size: 228 KB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing is voluntary under Reg FD for public dissemination of material information, with exhibits likely attached. No quantitative metrics, transactions, guidance, or events are disclosed in the filing summary.

24-02-2026

NovoCure Ltd filed a Form 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, guidance changes, or operational details are disclosed in the filing information provided. This appears to be a single-item voluntary disclosure with no quantitative data available.

24-02-2026

Bank of Marin Bancorp filed an 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, numerical data, positive or negative changes, or period-over-period comparisons are disclosed in the filing summary. This appears to be an informational disclosure without quantified impacts.

24-02-2026

Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-24 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts are provided in the available information. No positive or negative metrics reported.

24-02-2026

VenHub Global, Inc. filed a Form 8-K on February 24, 2026, reporting solely under Item 8.01 Other Events. No details on the core event, financial impacts, transactions, or metrics are disclosed. This is a voluntary, single-item informational filing with no quantitative data provided.

24-02-2026

CDT Equity Inc. filed an 8-K on February 24, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, parties involved, financial impacts, or strategic rationale are disclosed in the provided information. No quantitative metrics, period-over-period comparisons, positive or negative changes are mentioned.

24-02-2026

Wyndham Hotels & Resorts, Inc. filed an 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. No financial metrics, transactions, or quantitative data provided.

24-02-2026

CNX Resources Corp filed an 8-K on February 24, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific financial metrics, transactions, or performance data provided. No positive or negative metrics were mentioned.

24-02-2026

BuzzFeed, Inc. filed a Form 8-K on February 24, 2026, disclosing under Item 1.01 its entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed in the provided filing summary.

24-02-2026

Rank One Computing Corp dba ROC filed an 8-K on February 24, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details, dollar values, financial metrics, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary. This is a multi-item mandatory filing with no quantitative impacts or strategic context provided.

24-02-2026

La Rosa Holdings Corp. filed an 8-K on 2026-02-24 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, names, reasons for change, or any financial metrics are NOT_DISCLOSED.

24-02-2026

Eva Live Inc filed an 8-K on February 24, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific transaction values, share counts, financial metrics, or strategic details are disclosed in the provided filing summary. This multi-item disclosure indicates potentially significant corporate developments but lacks quantitative or qualitative context for impact assessment.

24-02-2026

Werewolf Therapeutics, Inc. filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the attached exhibits are disclosed in the provided filing information. This is a multi-item informational filing with no quantified financial metrics or directional impacts mentioned.

24-02-2026

PAR PACIFIC HOLDINGS, INC. filed an 8-K on February 24, 2026 (AccNo: 0001628280-26-011234), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are mentioned. Sector details are not specified.

• ·File size: 808 KB

24-02-2026

24-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-24 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), announcing events related to a merger/acquisition. No specific deal terms, parties, valuations, financial metrics, synergies, regulatory pathways, or shareholder impacts were disclosed. No quantitative data, period-over-period comparisons, or scheduled events were mentioned.

24-02-2026

Interparfums Inc filed an 8-K on 2026-02-24 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. Critical financial details such as dollar values, percentages, or comparisons are NOT_DISCLOSED.

24-02-2026

Dorchester Minerals, L.P. filed an 8-K on February 24, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, or quantitative data are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results.

24-02-2026

DIAMOND HILL INVESTMENT GROUP INC filed a Form 8-K on February 24, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information.